Advertisement

Topics

Allergan, Adamas: New Dosage Strengths For NAMZARIC Available In US

08:32 EDT 22 Sep 2016 | FinanzNachrichten

DUBLIN (dpa-AFX) - Allergan plc (AGN), a pharmaceutical company, and Adamas Pharmaceuticals, Inc. (ADMS) announced Thursday the U.S. availability of new dosage strengths for NAMZARIC (Memantine an...

Original Article: Allergan, Adamas: New Dosage Strengths For NAMZARIC Available In US

NEXT ARTICLE

More From BioPortfolio on "Allergan, Adamas: New Dosage Strengths For NAMZARIC Available In US"

Quick Search
Advertisement